Cronos (CRON): Price to Sales

Corporate company logo of Cronos Corp (CRON)

Oversupply in the sector limits the pricing power of Cronos Group Inc. (CRON), as confirmed by the historical P/S chart. The value of 6.10 captures the current state of the parameter. Capitalization growth relies on an asset-light model and biosynthesis supported by Altria, while supply stability is guaranteed by a diversified warehouse network synchronized with agricultural cycles.

CRON (Cronos) Price-to-Revenue Ratio history from 07/04/2022 to 11/13/2026

Cronos (CRON) - metric breakdowns and financial figures

- share price and consensus valuation forecast:
Price Performance Chart thecronosgroup.com|CRON - Price Target Chart
- stock exchange capitalization data:
Market Value Cronos|CRON - Total Company Value
- shareholders' equity book value data:
Equity per Share Cronos Group|CRON - Company Book Value|Market-to-Book Ratio thecronosgroup.com|CRON - Aggregate Company Assets
- issuer credit burden and liquidity indicators:
Total Debt to Capital Coefficient Cronos Group Inc.|CRON - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital Cronos Corp|CRON - Company Aggregate Debts|Debt to Net Assets Cronos|CRON - Company Long-Term Debt|Company Short-Term Loans and Borrowings Cronos Group|Immediate Liquidity thecronosgroup.com
- net income and valuation multiples indicators:
CRON - Net Income|Projected Future Earnings Cronos Group Inc.|CRON - Price to Earnings Ratio|Price to Expected Earnings Ratio Cronos Group Inc|CRON - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation Cronos|CRON - Operating profit EBITDA|Net earnings per share for the last four quarters Cronos Group|CRON - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last 12 months thecronosgroup.com|CRON - Earnings growth in current year|Expected earnings per share growth for next year Cronos Group Inc.
- total revenue and sales volume data:
CRON - Company Sales|Company Future Sales thecronosgroup.com|CRON - P/S Multiple|Forward Price-to-Revenue Multiple Cronos
General company analysis:Cronos Group Inc.
Core merchandise of Cronos Corp

The P/S multiple determines the market value of a business per unit of generated revenue, allowing for an assessment of the premium paid for an asset relative to its actual sales. By analyzing the historical P/S value of Cronos Group Inc. (CRON), an investor can compare the current valuation with market pressure and oversupply in the cannabis sector, which is critical as the competitive advantages of Cronos Group Inc. (CRON) erode due to slow legalization.

Competitors of Cronos Group Inc.

INDV (indivior.com) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Collegium Pharmaceutical, Inc. COLL|Canopy Growth Corp (CGC) - Price to Sales|HITI - Price-to-Revenue Ratio|ACB (Aurora Cannabis) - Market Cap to Revenue Ratio|Achieve Life Sciences (ACHV) - Price-to-Revenue Ratio|Price to Sales skyebioscience.com (SKYE)|Price-to-Revenue Ratio Anebulo Pharmaceuticals, Inc.|Canndoc (INCR) - Price-to-Revenue Coefficient|Market Cap to Revenue NTRB (Nutriband Inc.)|NSRX (nasuspharma.com) - Market Capitalization-to-Revenue Ratio|P/S Multiple IGC (IGC Pharma)|Price-to-Revenue Multiple MIRA Pharmaceuticals Inc.|FLGC - Price-to-Revenue Ratio|Market Capitalization-to-Revenue Ratio IMCC (IM Cannabis Corp.)|adialpharma.com (ADIL) - Price-to-Revenue Ratio|Price to Sales Artelo Biosciences, Inc. (ARTL)|Market Cap to Revenue ENSC|P/S Multiple Titan Pharma|Price-to-Revenue Ratio Greenlane (GNLN)|INM: Price-to-Sales Ratio|Akanda Corporation - Market Cap to Revenue|Market Capitalization-to-Revenue Ratio ENVB|Bright Green Corp - P/S Multiple|Price-to-Revenue Coefficient Hempacco Co Inc. HPCO